Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
This product will be manufactured at Lupin's Nagpur facility in India
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated
